VRCA - Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania.

52W High

$20.90

52W Low

$3.82

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.79

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-11.70

EV/Revenue (<3 favorable)

4.88

P/S (TTM) (<3 favorable)

3.28

P/B (<3 favorable)

238.54

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

43.45%

Institutions (25–75% balanced)

26.39%

Shares Outstanding

9,445,800

Float

1,935,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

14,704,000

Gross Profit (TTM)

5,010,000

EPS (TTM)

-7.74

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

0.12%

ROE (TTM) (>15% strong)

-15.47%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.45

Momentum

Bearish momentum

Value

-0.4432

-0.4253

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025